Carmell Therapeutics Corporation (CTCX) Stock Analysis

DELISTED 2025

What happened to Carmell Therapeutics Corporation (CTCX) stock?

Carmell Therapeutics Corporation (CTCX) no longer trades on public markets. It was delisted in March 2025. The figures below are historical and are not a current quote.

Status:: Delisted — no longer trades
Delisting date:: March 2025
Last recorded price (historical):: $0.1973 (last quote on record before the March 2025 delisting; historical, not a current quote)

MCap: $5.94M| Vol: 63.4K| 52-wk range: $0.1701 – $3.00

Market cap $5.94M is the value of all shares combined.

Data from FMP · Methodology

For informational purposes only. Not financial advice. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR

Carmell Therapeutics Corporation (CTCX). Carmell Therapeutics Corporation specializes in plasma-based bioactive materials for tissue regeneration, with its flagship product CT-101 targeting orthopedic, dental, and soft tissue healing applications.

Last analyzed: Jun 14, 2026

Carmell Therapeutics Corporation specializes in plasma-based bioactive materials for tissue regeneration, with its flagship product CT-101 targeting orthopedic, dental, and soft tissue healing applications. The company focuses on developing solutions to accelerate repair following injury, illness, or aging.

These figures come from statements filed 13 months ago — the most recent this company has published.

Carmell Therapeutics Corporation (CTCX) Healthcare & Pipeline Overview

Employees9

IndustryBiotechnology

SectorHealthcare

Model self-rating on this text: 69% (not a measure of the evidence) Updated: Jun 14, 2026

More about this archive record

Can I still buy CTCX shares?

No. CTCX stopped trading on public markets in March 2025, so the shares are not available through a broker. Anything you see quoted for CTCX elsewhere is historical data, not a live market.

Are the figures on this page current?

No. Every number here is the last value recorded before CTCX stopped trading. Nothing on this page updates, and none of it is a current quote.

Why does this page still exist?

Because people still search for what happened to Carmell Therapeutics Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Analysis updated Jun 14, 2026

Data Sources & Methodology

Figures come from Financial Modeling Prep (FMP). If FMP has no figure for a ticker, a price or fundamental may come from a Yahoo Finance fallback, or a price from an Alpaca fallback. SEC EDGAR is used only for filing links and company identity details (legal name, address), never for figures. Last updated: Jun 14, 2026.

Data provided for informational purposes only.